Article Per Year (5 Year)
p-Index From 2020 - 2025
0.444
P-Index
This Author published in this journals
All Journal Medical and Health Science Journal Indian Journal of Forensic Medicine & Toxicology
Hari Paraton
Unknown Affiliation
Health Professions Public Health Social Sciences

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Examination and Treatment Scenario in Urogynecology Case During COVID-19 Pandemic: A Review Eighty Mardiyan Kurniawati; Gatut Hardiyanto; Hari Paraton; Nur Anisah Rahmawati
Indian Journal of Forensic Medicine & Toxicology Vol. 15 No. 3 (2021): Indian Journal of Forensic Medicine & Toxicology
Publisher : Institute of Medico-legal Publications Pvt Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37506/ijfmt.v15i3.16021

Abstract

The number of COVID-19 cases continues to increase therefore health services in hospitals must adapt to the COVID-19 pandemic. One of the services that must be affected is urogynecology services. This study aims to examine scenarios in the examination and treatment of patients with urogynecological cases in hospitals during a pandemic. A non-systematic review examines several scientific articles related to recommendations. The articles were searched through the PubMed and Google Scholar databases with the keywords “urogynecology patient” or “hospital” or “treatment” or “urogynecology care” and “COVID-19”. Data is arranged in the form of scenarios and narrative reviews. The scenario carried out is telemedicine, except for certain severe cases, so one must go to the hospital with a record of patient protection against COVID-19. It is possible to use online to prevent the accumulation of patients in the hospital. Management emphasizes non-surgical solutions such as lifestyle, nutritional patterns, behavioral concepts, and periodic drug administration. Implementation is carried out with preconditions, namely patient safety, an integrated system related to payment and prescription of drugs. Things that need to be underlined in telemedicine governance are the need for adequate counseling and good cooperation between doctors and patients because this will affect diagnosis and management. This effort makes it possible to break the chain of infection in urogynecology services and the need for further research related to a complete and comprehensive application system
THE EFFECTIVENESS OF PRASTERONE VS PLACEBO THERAPY AS THE VULVOVAGINAL ATROPHY TREATMENT IN MENOPAUSAL WOMEN: META-ANALYSIS STUDY Zettira Maulida Prasha; Hari Paraton
Jurnal Ilmu Kesehatan dan Kesehatan Vol 4 No 2 (2020): AUGUST
Publisher : UNUSA Press

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33086/mhsj.v4i2.1656

Abstract

Background : Vulvovaginal atrophy is a condition that often occurs in menopausal women due to Estrogen decreased. Prasterone (DHEA) is a steroid hormone that can be converted into Estrogen in the target tissue. Objective : This paper aims to evaluate the effectiveness of administering Prasterone as Vulvovaginal Atrophy therapy in menopausal women. Methods : A systematic data search was performed on a medical database (PUBMED, Google scholar, Cochrane). Inclusion criteria: (1) randomized study of Prasterone as Vulvovaginal Atrophy therapy in postmenopausal women, (2) all-inclusive papers can be accessed completely, and (3) the data obtained can be accurately analysed. Results: Three RCTs with a total of 696 patients were analysed. The average number of Superficial Cells (mean difference [MD] 7.63, and 95% [CI] 7.57 to 7.70 (P <0.00001). The average number of Parabasal Cells (mean difference [MD] -29.84, and 95% [CI] -30.25 to -29.44 (P <0.00001). The average number of vaginal pH (mean difference [MD] -0.69, and 95% [CI] -0.70 to -0.68 (P <0.00001). The average number of Dyspareunia (mean difference [MD] -0.38, and 95% [CI] -0.39 to -0.37 (P <0.00001). All diamonds do not intersect the vertical line, and have p <0.05, it proves that there are significant differences between the two groups. All non-hysterectomized women have an atrophic or inactive endometrium. Side effects that are often complained of is headache and application site discharge. Conclusion This meta-analysis concludes that Prasterone therapy has a significant therapeutic effect for Vulvovaginal Atrophy in menopausal women
Co-Authors Eighty Mardiyan K, Eighty Gatut Hardiyanto Nur Anisah Rahmawati Zettira Maulida Prasha